alcoholic%20liver%20disease
ALCOHOLIC LIVER DISEASE
Alcoholic liver disease diagnosis is suggested by an established history of habitual alcohol intake of sufficient length and intensity.
Toxic daily threshold of alcohol consumption is 40-80 g for males and 20-40 g for females for 10-12 years.
Signs of alcohol abuse and hepatic injury include malnutrition and muscle wasting, cutaneous telangiectasia, palmar erythema, finger clubbing, Dupuytren's contracture, peripheral neuropathy, parotid gland enlargement and signs of gynecomastia and hypogonadism may also be present.

Introduction

Patient may present with signs and symptoms related to portal hypertension:
  • Abdominal wall collaterals
  • Ascites
  • Splenomegaly
  • Venous hum
  • Hepatic encephalopathy

Signs and Symptoms

Signs of Alcohol Abuse and Hepatic Injury

  • Malnutrition and muscle wasting
  • Jaundice
  • Cutaneous telangiectasia
  • Palmar erythema
  • Finger clubbing
  • Dupuytren’s contracture
  • Rhinophyma
  • Spider angioma
  • Peripheral neuropathy
  • Parotid gland enlargement
  • Signs of gynecomastia and hypogonadism may also be present

Others

  • Patient may be asymptomatic
  • Hepatomegaly, which is the most common sign in patients with alcoholic liver disease (ALD)
  • Hepatic bruit
  • Alcohol withdrawal (eg tremors, tachycardia, agitation, delirium tremens)
  • Anorexia, weight loss
  • Systemic inflammatory response syndrome (SIRS) (≥2 of the following: Heart rate >100 beats/minute, respiratory rate >12 breaths/minute, temperature >38°C or <36°C, WBC count >12,000 or <4000 mm)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Higher activity of plasma xanthine oxidase appears to be linked to insulin resistance and liver dysfunction among type 2 diabetes mellitus (T2DM) patients with metabolic syndrome (MetS), according to a recent Japan study.
6 days ago
Use of quetiapine among critically ill patients rarely leads to corrected QT (QTc) interval prolongation, reports a new study.
15 Jun 2018
New drug applications approved by US FDA as of 1 - 15 June 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Pearl Toh, 6 days ago
Drinking more water did not significantly slow down the decline in kidney function of patients with stage 3 chronic kidney disease (CKD) at 1 year compared with patients who maintained their daily water intake, the CKD WIT* randomized study suggests.